GOLD 2017

image_green.png


In the GOLD 2017 guidelines, the Bronchoscopic Lung Volume Reduction (BLVR) has been added as an Interventional Therapy in stable COPD with Evidence B:

“In select patients with advanced emphysema, bronchoscopic interventions reduces end-expiratory lung volume and improves exercise tolerance, health status and lung function at 6-12 months following treatment.” Coil Treatment is the only BLVR procedure in these guidelines that is independent of collateral ventilation.


Press Release
 

PneumRx® Coils included in new global clinical guidelines and given positive recommendation to treat severe emphysema patients in France.

December 05, 2016


Are you a Healthcare Professional?